• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

Threadneedle UK Equity Income RDR Z Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund ProviderThreadneedle Investment Services Ltd
Fund SummaryThe aim of the Fund is to provide income with the potential to grow the amount you invested. The Fund invests at least two-thirds of its assets in shares of UK companies. The Fund may also invest in asset classes and instruments different from those stated above. The Fund makes active investment decisions.
SEDOL codeB8169Q1
ISINGB00B8169Q14
Fund codeTHQIZ
ManagersRichard Colwell
Manager Tenure10 years
Morningstar CategoryUK Equity Income
IMA SectorUK Equity Income
Fund Size£2,147 million
Fund TypeOEIC
Management StyleActive
Ongoing Charge Figure (OCF)0.82%
Cavendish ongoing charge0.05%
FundsNetwork Service Fee0.20%
Minimum Initial Investment£25
Minimum Top Up£25
Minimum Monthly Investment£25
Sell Price£1.2080
Buy Price£1.2080
Price Change+2.4771%
Price Date28th September 2020
Yield4.16%
Dividend FrequencyQuarterly
ISA EligibleYes
SIPP EligibleYes
Inception Date22nd October 2012
Fund StatusOPEN
Richard Colwell is a portfolio manager and Head of UK Equities at Columbia Threadneedle. He manages the Threadneedle UK Growth & Income Fund, Threadneedle UK Equity Income Fund and the Threadneedle UK Equity Alpha Income Fund. He also co-manages the Threadneedle Monthly Extra Income Fund and has research responsibility across all sectors. Before joining the company, Richard ran high alpha UK equity portfolios at Aviva Investors. He has also held portfolio management roles at Credit Suisse and Schroders and worked at the Bank of England. Richard has a degree in Banking, Insurance & Finance from the University of Bangor. He holds the Chartered Financial Analyst designation and is a member of the CFA Society of the UK as well as the Chartered Institute of Bankers.

3-year Mean Monthly Return: -0.068%

Annual Returns2019201820172016201520142013201220112010
Fund Performance-8.19%-3.50%+5.71%+20.46%+3.32%+5.59%+18.89%+24.13%+1.39%+26.18%
Benchmark Performance
(UK Equity Income)
-14.88%-2.76%+5.09%+18.47%-1.43%
Time PeriodCumulativeBenchmark Performance
(UK Equity Income)
Fund Compared to Benchmark
1 day2.48%-22.14%+24.62%
1 week1.41%-1.72%+3.13%
1 month-0.51%-3.21%+2.70%
3 months-1.54%+9.15%-10.69%
6 months13.10%-16.92%+30.02%
1 year-12.15%-4.82%-7.33%
3 years-2.19%+0.86%-3.05%
5 years3.62%+5.23%-1.61%
10 years7.57%+9.94%-2.37%
YTD-17.04%+1.65%-18.69%
Since inception10.36%Currently unavailableCurrently unavailable

Top 10 shares for this fund

Share NameCountryValue
AstraZeneca PLCGBR10.23%
GlaxoSmithKline PLCGBR7.10%
Electrocomponents PLCGBR5.61%
Rentokil Initial PLCGBR5.54%
Imperial Brands PLCGBR4.76%
Phoenix Group Holdings PLCGBR4.20%
Morrison (Wm) Supermarkets PLCGBR4.01%
Unilever PLCGBR3.95%
RSA Insurance Group PLCGBR3.62%
3i OrdGBR2.98%
Dividend DatePer share amountReinvestment Price
8th September 20200.0105£1.2096
8th June 20200.0096£1.2639
9th March 20200.0110£1.2441
9th December 20190.0140£1.4291
9th September 20190.0150£1.4083
10th June 20190.0191£1.3683